Sartar Therapeutics develops treatment for soft tissue sarcomas. The focus of cancer therapy is moving towards personalised medicine. There is a clear unmet need to find new therapies for the broad and heterogeneous group of soft tissue sarcomas. We are committed to delivering innovative, therapeutic options for the patients who currently have no specific therapies and for those who have run out of all currently available options.
Company Details
- Employees
- 4
- Founded
- -
- Address
- Haartmaninkatu 4, Terkko Health Hub,finland
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://sartartherapeutics.com/
- Keywords
- Pharmaceuticals, Drug development, Startup, Oncology, Cancer treatment, Sarcomas, GIST, PDE3, Precision Medicine, Discovery Pipeline, Cancer.
- HQ
- Helsinki, Southern Finland
Sartar Therapeutics Questions
Sartar Therapeutics's website is https://sartartherapeutics.com/
Sartar Therapeutics's LinkedIn profile is https://fi.linkedin.com/company/sartar-therapeutics
Sartar Therapeutics has
4 employees.
View email and phone details for 4
employees at Sartar Therapeutics.
Sartar Therapeutics's industry is
Pharmaceutical Manufacturing
Sartar Therapeutics's top competitors are
Faron,
Tilt Biotherapeutics Ltd,
Draig Therapeutics,
Crst (Part Of Link Medical),
Upm Biomedicals,
Valo Therapeutics Ltd,
Herantis Pharma Plc.,
Biohit Oyj,
Admescope,
Aranda Pharma Ltd.
Sartar Therapeutics's categories are Pharmaceutical Manufacturing
Sartar Therapeutics's founding year is 2016
